Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 22


Periodic paralysis.

Fialho D, Griggs RC, Matthews E.

Handb Clin Neurol. 2018;148:505-520. doi: 10.1016/B978-0-444-64076-5.00032-6. Review.


Atypical periodic paralysis and myalgia: A novel RYR1 phenotype.

Matthews E, Neuwirth C, Jaffer F, Scalco RS, Fialho D, Parton M, Raja Rayan D, Suetterlin K, Sud R, Spiegel R, Mein R, Houlden H, Schaefer A, Healy E, Palace J, Quinlivan R, Treves S, Holton JL, Jungbluth H, Hanna MG.

Neurology. 2018 Jan 30;90(5):e412-e418. doi: 10.1212/WNL.0000000000004894. Epub 2018 Jan 3.


Somatosensory Evoked Potentials and Central Motor Conduction Times in children with dystonia and their correlation with outcomes from Deep Brain Stimulation of the Globus pallidus internus.

McClelland VM, Fialho D, Flexney-Briscoe D, Holder GE, Elze MC, Gimeno H, Siddiqui A, Mills K, Selway R, Lin JP.

Clin Neurophysiol. 2018 Feb;129(2):473-486. doi: 10.1016/j.clinph.2017.11.017. Epub 2017 Nov 24.


Effects of a Physical Activity Program on Cardiorespiratory Fitness and Pulmonary Function in Obese Women after Bariatric Surgery: a Pilot Study.

Onofre T, Carlos R, Oliver N, Felismino A, Fialho D, Corte R, da Silva EP, Godoy E, Bruno S.

Obes Surg. 2017 Aug;27(8):2026-2033. doi: 10.1007/s11695-017-2584-y.


CAV3 mutations causing exercise intolerance, myalgia and rhabdomyolysis: Expanding the phenotypic spectrum of caveolinopathies.

Scalco RS, Gardiner AR, Pitceathly RD, Hilton-Jones D, Schapira AH, Turner C, Parton M, Desikan M, Barresi R, Marsh J, Manzur AY, Childs AM, Feng L, Murphy E, Lamont PJ, Ravenscroft G, Wallefeld W, Davis MR, Laing NG, Holton JL, Fialho D, Bushby K, Hanna MG, Phadke R, Jungbluth H, Houlden H, Quinlivan R.

Neuromuscul Disord. 2016 Aug;26(8):504-10. doi: 10.1016/j.nmd.2016.05.006. Epub 2016 May 11.


Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies.

Suetterlin KJ, Bugiardini E, Kaski JP, Morrow JM, Matthews E, Hanna MG, Fialho D.

JAMA Neurol. 2015 Dec;72(12):1531-3. doi: 10.1001/jamaneurol.2015.2338. No abstract available.


Diagnosis of skeletal muscle channelopathies.

Spillane J, Fialho D, Hanna MG.

Expert Opin Med Diagn. 2013 Nov;7(6):517-29. doi: 10.1517/17530059.2013.839656. Epub 2013 Sep 26. Review.


Non-dystrophic myotonia: prospective study of objective and patient reported outcomes.

Trivedi JR, Bundy B, Statland J, Salajegheh M, Rayan DR, Venance SL, Wang Y, Fialho D, Matthews E, Cleland J, Gorham N, Herbelin L, Cannon S, Amato A, Griggs RC, Hanna MG, Barohn RJ; CINCH Consortium.

Brain. 2013 Jul;136(Pt 7):2189-200. doi: 10.1093/brain/awt133. Epub 2013 Jun 13.


Prevalence study of genetically defined skeletal muscle channelopathies in England.

Horga A, Raja Rayan DL, Matthews E, Sud R, Fialho D, Durran SC, Burge JA, Portaro S, Davis MB, Haworth A, Hanna MG.

Neurology. 2013 Apr 16;80(16):1472-5. doi: 10.1212/WNL.0b013e31828cf8d0. Epub 2013 Mar 20.


A new explanation for recessive myotonia congenita: exon deletions and duplications in CLCN1.

Raja Rayan DL, Haworth A, Sud R, Matthews E, Fialho D, Burge J, Portaro S, Schorge S, Tuin K, Lunt P, McEntagart M, Toscano A, Davis MB, Hanna MG.

Neurology. 2012 Jun 12;78(24):1953-8. doi: 10.1212/WNL.0b013e318259e19c. Epub 2012 May 30.


Refined exercise testing can aid DNA-based diagnosis in muscle channelopathies.

Tan SV, Matthews E, Barber M, Burge JA, Rajakulendran S, Fialho D, Sud R, Haworth A, Koltzenburg M, Hanna MG.

Ann Neurol. 2011 Feb;69(2):328-40. doi: 10.1002/ana.22238.


The non-dystrophic myotonias: molecular pathogenesis, diagnosis and treatment.

Matthews E, Fialho D, Tan SV, Venance SL, Cannon SC, Sternberg D, Fontaine B, Amato AA, Barohn RJ, Griggs RC, Hanna MG; CINCH Investigators.

Brain. 2010 Jan;133(Pt 1):9-22. doi: 10.1093/brain/awp294. Epub 2009 Nov 16. Review.


Non-genomic effects of sex hormones on CLC-1 may contribute to gender differences in myotonia congenita.

Fialho D, Kullmann DM, Hanna MG, Schorge S.

Neuromuscul Disord. 2008 Nov;18(11):869-72. doi: 10.1016/j.nmd.2008.07.004. Epub 2008 Sep 23.


Periodic paralysis.

Fialho D, Hanna MG.

Handb Clin Neurol. 2007;86:77-106. doi: 10.1016/S0072-9752(07)86004-0. No abstract available.


What causes paramyotonia in the United Kingdom? Common and new SCN4A mutations revealed.

Matthews E, Tan SV, Fialho D, Sweeney MG, Sud R, Haworth A, Stanley E, Cea G, Davis MB, Hanna MG.

Neurology. 2008 Jan 1;70(1):50-3. doi: 10.1212/01.wnl.0000287069.21162.94.


Chloride channel myotonia: exon 8 hot-spot for dominant-negative interactions.

Fialho D, Schorge S, Pucovska U, Davies NP, Labrum R, Haworth A, Stanley E, Sud R, Wakeling W, Davis MB, Kullmann DM, Hanna MG.

Brain. 2007 Dec;130(Pt 12):3265-74. Epub 2007 Oct 11.


POLG1, C10ORF2, and ANT1 mutations are uncommon in sporadic progressive external ophthalmoplegia with multiple mitochondrial DNA deletions.

Hudson G, Deschauer M, Taylor RW, Hanna MG, Fialho D, Schaefer AM, He LP, Blakely E, Turnbull DM, Chinnery PF.

Neurology. 2006 May 9;66(9):1439-41.


Phenotypic spectrum associated with mutations of the mitochondrial polymerase gamma gene.

Horvath R, Hudson G, Ferrari G, F├╝tterer N, Ahola S, Lamantea E, Prokisch H, Lochm├╝ller H, McFarland R, Ramesh V, Klopstock T, Freisinger P, Salvi F, Mayr JA, Santer R, Tesarova M, Zeman J, Udd B, Taylor RW, Turnbull D, Hanna M, Fialho D, Suomalainen A, Zeviani M, Chinnery PF.

Brain. 2006 Jul;129(Pt 7):1674-84. Epub 2006 Apr 18.


Treatment of chronic inflammatory demyelinating polyradiculoneuropathy with methotrexate.

Fialho D, Chan YC, Allen DC, Reilly MM, Hughes RA.

J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):544-7.


Predicting response to treatment in chronic inflammatory demyelinating polyradiculoneuropathy.

Chan YC, Allen DC, Fialho D, Mills KR, Hughes RA.

J Neurol Neurosurg Psychiatry. 2006 Jan;77(1):114-6.

Supplemental Content

Loading ...
Support Center